Medtronic (MDT) gains after boosting full-year guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St set for higher open as AI stocks rise, oil slides
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
- Crypto stocks rise premarket as Bitcoin hits over seven-month high
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Streamflation drives 39% of Americans to cancel streaming in 6 months
- FortuneX and WT Realty announce $600M merger deal
Medtronic (MDT) Tops Q3 EPS by 4c; raises FY24 Guidance
February 20, 2024 7:03 AM ESTMedtronic (NYSE: MDT) reported Q3 EPS of $1.30, $0.04 better than the analyst estimate of $1.26. Revenue for the quarter came in at $8.1 billion versus the consensus estimate of $7.95 billion.
GUIDANCE:
Medtronic sees FY2024 EPS of $5.19-$5.21, versus the consensus of $5.16.
The... More
Medtronic (MDT) to Exit Ventilator Product Line, Reports Q3, Issues Guidance
February 20, 2024 6:47 AM ESTMedtronic plc (NYSE: MDT) today announced financial results for its third quarter (Q3) of fiscal year 2024 (FY24), which ended January 26, 2024.
Patient Monitoring and Respiratory Interventions (PMRI) Update
Medtronic has decided to exit its ventilator product line and retain and combine the remaining PMRI businesses into one business unit called Acute Care and Monitoring (ACM). Exiting the increasingly unprofitable ventilator product line and combining the remaining businesses allows for increased investment in ACM with a focus on profitable growth. Given this increased investment... More
Medtronic (MDT) call put ratio 4.2 calls to 1 put into quarter results
February 16, 2024 10:42 AM ESTMedtronic (NYSE: MDT) February weekly call option implied volatility is at 33, March is at 34; compared to its 52-week range of 15 to 29 into the expected release of quarter results before the bell on February 20.
... MoreMedtronic (MDT) February weekly 85 straddle into quarter results
February 16, 2024 4:58 AM ESTMedtronic (NYSE: MDT) February weekly 85 straddle priced for a move of 5% into the expected release of quarter results before the bell on February 20.
... More
